Cavarretta R - Search Results

1

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

Bucello S, Annovazzi P, Ragonese P, Altieri M, Barcella V, Bergamaschi R, Bianchi A, Borriello G, Buscarinu MC, Callari G, Capobianco M, Capone F, Cavalla P, Cavarretta R, Cortese A, De Luca G, Di Filippo M, Dattola V, Fantozzi R, Ferraro E, Filippi MM, Gasperini C, Grimaldi LME, Landi D, Re ML, Mallucci G, Manganotti P, Marfia GA, Mirabella M, Perini P, Pisa M, Realmuto S, Russo M, Tomassini V, Torri-Clerici VLA, Zaffaroni M, Zuliani C, Zywicki S, Filippi M, Prosperini L. Bucello S, et al. Among authors: cavarretta r. J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22. J Neurol. 2021. PMID: 33616742

2

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.

Mallucci G, Annovazzi P, Miante S, Torri-Clerici V, Matta M, La Gioia S, Cavarretta R, Mantero V, Costantini G, D'Ambrosio V, Zaffaroni M, Ghezzi A, Perini P, Rossi S, Bertolotto A, Rottoli MR, Rovaris M, Balgera R, Cavalla P, Montomoli C, Bergamaschi R. Mallucci G, et al. Among authors: cavarretta r. J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14. J Neurol. 2018. PMID: 29948245

3

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.

Oreja-Guevara C, Rovaris M, Iannucci G, Valsasina P, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Comi G, Filippi M. Oreja-Guevara C, et al. Among authors: cavarretta r. Arch Neurol. 2005 Apr;62(4):578-84. doi: 10.1001/archneur.62.4.578. Arch Neurol. 2005. PMID: 15824256 Clinical Trial.

4

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M. Oreja-Guevara C, et al. Among authors: cavarretta r. Arch Neurol. 2006 May;63(5):736-40. doi: 10.1001/archneur.63.5.736. Arch Neurol. 2006. PMID: 16682543

5

Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study.

Charil A, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Filippi M. Charil A, et al. Among authors: cavarretta r. Mult Scler. 2006 Oct;12(5):662-5. doi: 10.1177/1352458506070714. Mult Scler. 2006. PMID: 17086915

6

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.

Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G. Gironi M, et al. Among authors: cavarretta r. Mult Scler. 2008 Sep;14(8):1076-83. doi: 10.1177/1352458508095828. Mult Scler. 2008. PMID: 18728058

7

Fingolimod effects on left ventricular function in multiple sclerosis.

Racca V, Di Rienzo M, Cavarretta R, Toccafondi A, Vaini E, Ferratini M, Rovaris M. Racca V, et al. Among authors: cavarretta r. Mult Scler. 2016 Feb;22(2):201-11. doi: 10.1177/1352458515587753. Epub 2015 Jun 3. Mult Scler. 2016. PMID: 26041795

8

Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis.

Saresella M, Marventano I, Speciale L, Ruzzante S, Trabattoni D, Della Bella S, Filippi M, Fasano F, Cavarretta R, Caputo D, Clerici M, Ferrante P. Saresella M, et al. Among authors: cavarretta r. J Neuroimmunol. 2005 Sep;166(1-2):173-9. doi: 10.1016/j.jneuroim.2005.05.010. J Neuroimmunol. 2005. PMID: 16161213

9

Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.

Racca V, Di Rienzo M, Cavarretta R, Toccafondi A, Vaini E, Ferratini M, Rovaris M. Racca V, et al. Among authors: cavarretta r. Mult Scler. 2016 Apr;22(5):708-9. doi: 10.1177/1352458515600251. Epub 2015 Sep 10. Mult Scler. 2016. PMID: 26359278 No abstract available.

10

Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Ghezzi A, Mutta E, Bianchi F, Bonavita S, Buttari F, Caramma A, Cavarretta R, Centonze D, Coghe GC, Coniglio G, Del Carro U, Ferrò MT, Marrosu MG, Patti F, Rovaris M, Sparaco M, Simone I, Tortorella C, Bergamaschi R. Ghezzi A, et al. Among authors: cavarretta r. Neurol Sci. 2016 Mar;37(3):437-42. doi: 10.1007/s10072-015-2415-7. Epub 2015 Nov 27. Neurol Sci. 2016. PMID: 26613723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page